Delivery Order SPE2DB20D2104-SPE2DB25FNBTR
- Not listed
- On June 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,766.50 to AmerisourceBergen Drug Corp for the supply of Dicyclomine 20 mg tablets (1,000 count). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Dicyclomine 20 mg, a medication commonly used to treat irritable bowel syndrome and related gastrointestinal conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,294.10 under firm fixed price terms, with an ultimate completion date of August 21, 2025. The order was issued on August 20, 2025, and will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dicyclomine 20 mg/2 mL vials with a ceiling value of $1,590.47. This contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and was awarded on a competitive basis without set-aside restrictions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dicyclomine 20 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,589.92 and an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dicyclomine is an anticholinergic medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Dicyclomine 20 mg, a medication commonly used to treat irritable bowel syndrome and related gastrointestinal conditions. This competitively awarded, non-set-aside contract has a ceiling value of $2,388.55 and was finalized on July 30, 2025, with an ultimate completion date of July 31, 2025. The award utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-five dollars and eighty-two cents to Amerisourcebergen Drug Corporation for one thousand units of 20mg dicyclomine tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is from August 28, 2023 through August 29, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred fifty-five dollars and eighty-two cents to Amerisourcebergen Drug Corporation for one thousand tablets of 20mg dicyclomine. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform the contract from its location in Conshohocken, Pennsylvania. The order is for the supply of the specified pharmaceutical product to the Defense Logistics Agency...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,104.99, is for the delivery of DICYCLOMINE HCL INJ5S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Difici 200 mg tablets in quantities of 20 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,852.71 and an ultimate completion date of August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.17 to AmerisourceBergen Drug Corp on September 11, 2025, with an ultimate completion date of September 12, 2025. The order is for pharmaceutical products identified as "4569424878 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" under a firm fixed price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBTRDelivery Order
The Defense Logistics Agency awarded a $1,161.57 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Dicyclomine 20 mg, with a completion date of September 29, 2025. This competitively awarded contract, issued on September 26, 2025, carries no set-aside designation and employs firm fixed-price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills similar delivery orders for generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/26/25 |